VanEck Associates’s Axogen AXGN Stock Holding History

VanEck Associates’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$272K	Buy	+5,889	New	+$237K	﹤0.01%	1276

Other funds holding AXGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

VanEck Associates's AXGN Position: Q2 2026 in Review

VanEck Associates opened a new position in Axogen (AXGN) in Q2 2026: 5,889 shares worth $272K. The stake represents ﹤0.01% of the portfolio and ranks #1276 among its holdings.

253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

VanEck Associates held 5,889 shares of Axogen worth $272K as of Q2 2026.
Axogen was a new VanEck Associates position in Q2 2026.
Axogen made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1276 holding.
253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.